{"slideshow_credits": null, "snippet": "The company said it would apply for approval to use palbociclib with a drug called Femara, or letrozole, as an initial treatment for postmenopausal women with a certain type of advanced breast cancer.", "abstract": "Pfizer says Food and Drug Administration will allow it to apply for approval of its heavily promoted experimental breast cancer medicine based on midstage patient testing results.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/05/17/business/pfizer-to-apply-for-breast-cancer-drug-approval.html", "lead_paragraph": "The company said it would apply for approval to use palbociclib with a drug called Femara, or letrozole, as an initial treatment for postmenopausal women with a certain type of advanced breast cancer.", "headline": {"main": "Pfizer to Apply for Breast Cancer Drug Approval", "print_headline": "Pfizer to Apply for Breast Cancer Drug Approval", "content_kicker": "Business Briefing"}, "_id": "5376907e38f0d821cdd017cf", "word_count": "171", "multimedia": [], "pub_date": "2014-05-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Pfizer Inc", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Breast Cancer", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Women and Girls", "name": "subject", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}